Mendoza RMA, Ramírez AMC

Language: Spanish
References: 30
Page: 165-179
PDF size: 262.65 Kb.

ABSTRACT

The diabetic foot (DF) is a complication of diabetes mellitus, and those who suffer it have 30 more times probabilities to result in amputation. This complication is characterized by neuroischemic manifestations, infection and foot deformities. The beginning of the clinical alteration of DF is due to a loss of metabolic control, as well as in alterations in several mechanisms, such as neuropathic, microvascular and macrovascular in which the atheroma plaque is built, following a progression and evolution of neurovascular complications. The most accepted classification for this illness is the one of Wagner. The physiopathologic process of DF must be handled in an integral form, because all of these occur simultaneously, and should be handled in a multidisciplinary approach. In this article, it is discussed how the physicians with different clinical specialty interact in the diagnosis and treatment of DF, boarding the diabetic neuropathy, the diagnosis procedures, the pharmacological treatment, and the occurrence of infections caused by fungi and by bacteria. It is also discussed the correct, rational use of antibiotics and the surgical and clinical procedures for each individual case, according to the type of injury, the current diagnosis and treatment of vascular peripherical insufficiency and its differential diagnosis as well as its medical and surgical treatment. As an extreme case of diabetic neuropathy is considered the Charcot’s foot. Another discussed topic in this article is the orthopodologic treatment and prevention and education of patients presenting high risk for DF.

REFERENCES

1. Rosas GJ, Zacarías CR. Grupo Consenso en Prevención de Complicaciones Crónicas de la Diabetes Mellitus Tipo 2. Revista de Endocrinología y Nutrición 2004; 12: S45-S49.

2. Martínez JFR, Mendiola SI, Ramos CF. Epidemiología y costos de atención del pie diabético. En: Martínez JFR. Pie diabético atención integral. Segunda Edición. México; McGraw-Hill 2004: 5-18.

3. Marañes JP, Pallardo DR, Mubark A. Atlas de la diabetes y sus complicaciones. Madrid Edimsa Editores, 2002.

4. Brownlee M, Aiello A, Friedman E, Vinik A, Nesto R, Boulton A. Complicaciones de la diabetes mellitus. En: Williams, Tratado de endocrinología. Larsen R, Kronenberg H, Melmed S, Polonsky K. Décima edición. Madrid; Saunders Elsevier 2004: 1625-1702.

5. Arana CV, Méndez FI. Fisiopatología de las complicaciones vasculares pie diabético. Gac Méd Méx 2003; 139: 255-264.

6. Wagner FW. The dysvascular foot: A system for diagnosis and treatment. Foot Ankle 1981; 2: 64-122.

7. Oyibo S, Jude E, Tarawneh I, Samson O, Oyibo SO, Jude EB, Hienvu C, Nguyen HC, Harkless LB, Boulton AJM. A comparison of two diabetic foot ulcer classification systems. Diabetes Care 2001; 24: 84-88.

8. Lavery DG, Armstrong DG, Harkless LB. Classification of diabetic foot wounds. J Foot Ankle Surg 1996; 35: 528.

9. Ramos HG. Clasificación del pie diabético. En: Martínez JFR. Pie diabético atención integral. Segunda edición. México; McGraw-Hill 2004: 79-96.

10. Boulton AJ, Gries FA, Jervell JA. Guidelines for the diagnosis and management of diabetic peripheral neuropathy. Diabet Med 1998; 15: 508-514.

11. Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA 2005; 293: 217-228.

12. Gómez PF, Hernández JS, Rull JA. Avances en el tratamiento de las manifestaciones sensitivas de la neuropatía diabética. Revista de Endocrinología y Nutrición 2002; 10: 77-83.

13. Tom CM, Kane MP. Management of toenail onychomycosis. Am J Health Syst Pharm 1999; 56: 865-871.

14. Watkins Pi. ABC of diabetes: The diabetic foot. BMJ 2003; 326: 977-979.

15. López AS, López AF. Insuficiencia vascular periférica diabetes mellitus y lesiones del pie. Salud Pública de México 1998; 40: 281-292.

16. Zgonis T, Roukis TS. A systematic approach to diabetic foot infections. Adv Ther 2005; 22: 244-262.

17. Martínez GD. Tratamiento de la infección en el pie diabético. Cir Esp 2004; 76: 9-15.

18. Salas CL, Gómez FO, Villar MH, Martín RB. Antisépticos, clorhexidina. Rev Rol Enf 2000; 23: 637-664.

19. McDonnell G, Denver A. Antiseptics and disinfectants: Activity action and resistance. Clin Microb Rev 1999; 12: 147-149.

20. Yahagi N, Kono M, Kitahara M, Ohmura A, Sumita O, Hashimoto T, Hori K, Ning C, Woodson P, Kubota S, Murakami A, Takamoto S. Effect of electrolyzed water on wound healing. Artificial Organs 2000; 24: 984-987.

21. Nakae H, Inaba H. Effectiveness of electrolyzed oxidized water irrigation in a burn-wound infection model. J Trauma 2000; 49: 511-514.

22. Pudner R. Wound management: alginate and hydrofibre dressings in wound management. Journal of Community Nursing 2001; 15: 5.

23. Timmons J. Alginates and hydrofibre dressings. Professional Nurse 1999; 14: 496-503.

24. Yamaguchi Y, Yoshida S, Sumikawa Y, Kubo T, Hosokawa K, Ozawa K et al. Rapid healing of intractable diabetic foot ulcers with exposed bones following a novel therapy of exposing bone marrow cells and then grafting epidermal sheets. Br J Dermatol 2004; 151: 1019-1028.

25. Rivera SG, Lázaro MJ, March GJ. Exploración vascular en el pie diabético. En: Aragón-Sánchez FJ, Lázaro-Martínez JL. Atlas del manejo práctico del pie diabético. Madrid; CPG 2004: 36.

26. Doly M, Droy-Lefaix MT. Effect of Ginkgo biloba extract on the electrophysiology of the isolated diabetic rat retina, recent results in pharmacology and clinic. Springer-Verlag 1988: 83-90.

27. Sociedad Mexicana de Nutrición y Endocrinología, Asociación de Medicina Interna de México, Sociedad de Nutriología. Consenso para la prevención de las complicaciones crónicas de la diabetes tipo 2. Rev Invest Clin 2000; 52: 325-363.

28. Mills JL. Evaluation and management of peripheral arterial disease. In: Armstrong DG, Lavary LA. Clinical care of the diabetic foot. USA; American Diabetes Association 2004: 99-106.

29. Wunderlich RP, Peters EJ, Lavery LA. Systemic hyperbaric oxygen therapy: lower-extremity wound healing and the diabetic foot. Diabetes Care 2000; 23: 1551-1555.

30. Cueva AV, Mejía MJ, Luengas VD, Salinas SO. Complicaciones del pie diabético. Rev Med IMSS 2003; 41: 97-104.